Regulatory proteins common to all eukaryotic cells can have additional, unique functions in embryonic stem cells, according to a new study. If cancer progenitor cells — which function similarly to stem cells — are shown to rely on these regulatory proteins in the same way, it may be possible to target them therapeutically without harming healthy neighboring cells.